Scalable high-density peptide arrays for comprehensive health monitoring


There is an increasing awareness that health care must move from post-symptomatic treatment to presymptomatic intervention. An ideal system would allow regular inexpensive monitoring of health status using circulating antibodies to report on health fluctuations. Recently, we demonstrated that peptide microarrays can do this through antibody signatures (immunosignatures). Unfortunately, printed microarrays are not scalable. Here we demonstrate a platform based on fabricating microarrays (~10 M peptides per slide, 330,000 peptides per assay) on silicon wafers using equipment common to semiconductor manufacturing. The potential of these microarrays for comprehensive health monitoring is verified through the simultaneous detection and classification of six different infectious diseases and six different cancers. Besides diagnostics, these high-density peptide chips have numerous other applications both in health care and elsewhere.



Joseph Barten Legutki1, Zhan-Gong Zhao1, Matt Greving2, Neal Woodbury1, Setephen Albert Johnston1 & Phillip Stafford1

  • 1. Center for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona 85287, USA
  • 2. NextVal, 4186 Sorrento Valley Boulevard, Suite G, San Diego, California 92121, USA


Parc d'activités Activestre
31390 Carbonne - FRANCE


Phone +33 561 971 974
Fax +33 561 971 975